Inacelissp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-05-25
Share capital
500 000,00 PLN
Registered address
ul. Marsz. Józefa Piłsudskiego 74/320, 50-020 Wrocław, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 1995 days for 2019).

  • 2025not filed
  • 2024filed
  • 202309/04/2026
  • 202207/04/2026
  • 202107/04/2026
  • 202007/04/2026
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 122.80kMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD 4.55kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 118.25kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 531.28kMedianUSD 133.19kAverageUSD 3.03m

Authorized Representatives

Anna Ziemnicka – President of the Management Board

Manner of representation

In the case of a one-person management board, declarations of will on behalf of the company are made by the member of the management board. In the case of a management board consisting of two or more members, the joint action of two members of the management board or of one member of the management board or of one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
Damian Łukasz Szpryncage 42
950$128,309.0295%
Others
50$6,753.115%

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2021-09-11 to 2026-03-19.

Reason for removal: Art. 96 ust. 9 pkt 4 (taxpayer or their representative fails to appear on summons of tax authorities)

Debt

1 closed proceeding recorded in KRZ history.

Registration dateProceeding typeStatus
Apr 29, 2022
Discontinued enforcement proceedings
Closed

Public aid

4 public aid cases recorded, with a total value of $330,404.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid for research and development projects: industrial research
$234.7K
Aid for research and development projects: experimental development
$91,327

European Funds

ProjectEU co-financing
Development of an innovative dietary supplement that reduces the risk of developing atherosclerosis
$329.1K

Competitors

Name
Vitrotest Europesp. z o.o.
VASA Therapeuticssp. z o.o.
MultiqureS.A.
AI Corelabsp. z o.o.
Relvosp. z o.o.
Microblicsp. z o.o.
Biodecsp. z o.o.
GenomtecS.A.
Centrum Transferu Technologii Meditransfer Iitdsp. z o.o.
Olenasp. z o.o.

Change history

DateEvent
2020-11-25Share capital change
2017-05-25Entered in the register

FAQ

Last updated: 2026-04-09